Baseline Low-Density Lipoprotein Cholesterol Levels and Outcome in Patients With Heart Failure

American Journal of Cardiology

Volumn 105, Issue 1, 2010, Pages 100-104

  Charach, Gideon ^a   George, Jacob ^a   Roth, Arie ^a   Rogowski, Ori ^a   Wexler, Dov ^a   Sheps, David ^a   Grosskopf, Itamar ^a   Weintraub, Moshe ^a   Keren, Gad ^a   Rubinstein, Ardon ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CAUSE OF DEATH; CHOLESTEROL, LDL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ISRAEL; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 72049116800     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.08.660     Document Type: Article

References (29)

1. Ford I., Murray H., Packard C.J., Shepherd J., Macfarlane P.W., Cobbe S.M., and West of Scotland Coronary Prevention Study Group. Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med 357 (2007) 1477-1486
2. Pedersen T.R., Kjekshus J., Berg K., Haghfelt T., Faergeman O., Faergeman T., Pyorala K., Miettinen T., Wilhelmsen L., Olsson A.G., and Wedel H. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) 1994. Atheroscler Suppl 5 (2004) 81-87
3. Raina A., Pickering T., and Shimbo D. Statin use in heart failure: a cause for concern?. Am Heart J 152 (2006) 39-49
4. Tousoulis D., Charakida M., Stefanadi E., Siasos G., Latsios G., and Stefanadis C. Statins in heart failure. Beyond the lipid lowering effect. Int J Cardiol 115 (2007) 144-150
5. Khush K.K., and Waters D.D. Effects of statin therapy on the development and progression of heart failure: mechanisms and clinical trials. J Card Fail 12 (2006) 664-674
6. Sakatani T., Shirayama T., Suzaki Y., Yamamoto T., Mani H., Kawasaki H., Sugihara H., and Matsubara H. The association between cholesterol and mortality in heart failure. Comparison between patients with and without coronary artery disease. Int Heart J 46 (2005) 619-629
7. Domanski M., Coady S., Fleg J., Tian X., and Sachdev V. Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the Beta-blocker Evaluation of Survival Trial [BEST]). Am J Cardiol 99 (2007) 1448-1450
8. von Haeling S., Okonko D.O., and Anker S.D. Statins: a treatment option for chronic heart failure?. Heart Fail Monit 4 (2004) 90-97
9. Krum H., and McMurray J. Statins and chronic heart failure: do we need a large-scale outcomes trial?. J Am Coll Cardiol 39 (2002) 1567-1573
10. Krum H., Latini R., Maggioni A., Anand I., Masson S., Carretta E., Ingrilli F., Pettinati G., Glazer R., Tognoni G., and Cohn J. Statins and symptomatic chronic systolic heart failure: a post hoc analysis of 5010 patients enrolled in Val-HeFT. Int J Cardiol 119 (2007) 48-53
11. Go A., Lee W., Yang J., Lo G.C., and Gurwitz J.H. Statin therapy and risk for death and hospitalization in chronic heart failure. JAMA 296 (2006) 2105-2111
12. Krum H., Ashton E., Reid C., Kalff V., Rogerd J., Amarena J., Singh B., and Tonkin A. Double-blind, randomized, placebo-controlled study of high dose HMG COA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic heart failure. J Card Fail 13 (2007) 1-7
13. Bohm M., Hjalmarson A., Kjeksus J., Laufs U., McMurray J., and van Veldhuisen D.J. Heart failure and statins-why do we need a clinical trial?. Z Kardiol 94 (2005) 223-230
14. Rauchhaus M., Clarc A.L., Doehner W., Davos C., Bolger A., Sharma R., Coats A.J., and Ank S.D. The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 42 (2003) 1933-1940
15. Clearfield M. Rosuvastatin in older patients with systolic heart failure. Curr Atheroscler Rep 11 (2009) 5-6 8
16. Alehagen U., Lindshtedt G., Levin L., and Dahistrom U. The risk of cardiovascular death in elderly patients with possible heart failure. Results from 6-year follow-up of Swedish primary care population. Int J Cardiol 100 (2005) 17-27
17. Horwich T.B., Hamilton M., Maclellan W., and Fonarew G.C. Low total serum cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 8 (2002) 216-224
18. Iwaoka M., Obata J.E., Abe M., Nakamura T., Kitta Y., Kodama Y., Kawabata K., Takano H., Fujioka D., Sayto Y., Kobayashi T., Hasebe H., and Kuqiyama K. Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure. J Card Fail 13 (2007) 247-253
19. Aronov S.W., and Ahn C. Frequency of congestive heart failure in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug. Am J Cardiol 90 (2002) 147-149
20. Afsarmanesh N., Horwich T.B., and Fonarow G.C. Total cholesterol levels and mortality risk in nonischemic systolic heart failure. Am Heart J 152 (2006) 1077-1083
21. Richartz B.M., Radovancevic B., Frazier O.H., Vaughn W.K., and Taegtmeyer H. Low serum cholesterol levels predict high perioperative mortality in patients supported by left ventricular assist system. Cardiology 89 (1998) 184-188
22. Fraunberger P., Nagel D., Walli A.K., and Seidel D. Serum cholesterol and mortality in patients with multiple organ failure. Crit Care Med 28 (2000) 3574-3575
23. Liu Y., Coresh J., Eustace J.A., Longenecker J.C., Jaar B., Fink N.E., Tracy R.P., Powe N.R., and Klag M.J. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 291 (2004) 451-459
24. Schatz U., Masaki K., Yano K., Chen R., Rodriguez B.L., and Curb J.D. Cholesterol and all cause mortality in elderly people from Honolulu Heart Program: a cohort study. Lancet 358 (2001) 351-355
25. Tikhonoff V., Casiglia E., Mazza A., Scarpa R., Thijs L., Pessina A.C., and Staessen J.A. Low-density lipoprotein cholesterol and mortality in older people. J Am Geriatr Soc 53 (2005) 2159-2164
26. Anand I.S., Latini R., Florea V.G., Kuskowski M.A., Rector T., Masson S., Signorini S., Mocarelli P., Hester A., Glazer R., and Cohn J.N. C-reactive protein in heart failure: prognostic value and effect of valsartan. Circulation 112 (2005) 1428-1434
27. Deswal A., Petersen N.J., Feldman A.M., Young J.B., White B.G., and Mann D.L. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from Vesnarinone Trial (VEST). Circulation 103 (2001) 2055-2059
28. Harris H.W., Grunfeld C., Feingold K.R., and Rapp J.H. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 86 (1990) 696-702
29. Christ M., Klima T., Grimm W., Mueller H.H., and Maisch B. Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy. Eur Heart J 27 (2006) 691-699